Application of a ready to use calcium ionophore increases rates of fertilization and pregnancy in severe male factor infertility

Patients with severe male factor infertility treated with a ready-to-use ionophore achieve high fertilization and pregnancy rates.

Like Comment

Authors

Thomas Ebner, Ph.D., Maria Köster, Ph.D., Omar Shebl, M.D., Marianne Moser, Ph.D., Hans Van der Ven, M.D., Gernot Tews, M.D., Markus Montag, Ph.D.

Volume 98, Issue 6, Pages 1432-1437, December 2012

Abstract

Study objective:

To analyze whether a ready-to-use calcium ionophore improves outcome from fertilization to life birth in patients with severe male factor infertility.

Design:

Artificial oocyte activation was offered to all such patients in a 20-month period.

Setting:

Specialized in vitro fertilization (IVF) centers in Austria and Germany.

Patients:

Twenty-nine azoospermic and 37 cryptozoospermic patients participated.

Interventions:

Mature oocytes treated with a ready-to-use Ca2+-ionophore (GM508 Cult-Active) immediately after intracytoplasmic sperm injection (ICSI).

Main outcome measure(s):

Rates of fertilization, implantation, clinical pregnancy, and live birth.

Results:

Patients had had 88 previous cycles without artificial activation that resulted in a fertilization rate of 34.7%, 79 transfers (89.8%), and 5 pregnancies, which all spontaneously aborted except one. After artificial oocyte activation, the fertilization rate was 56.9%. In terms of fertilization rate, both azoospermic (64.4%) and cryptozoospermic (48.4%) men statistically significantly benefited from use of the ionophore. In 73 transfer cycles, positive β-human chorionic gonadotropin levels were observed in 34 cases (46.6%) and 29 cycles (39.7%) that ended with a clinical pregnancy. The corresponding implantation rate was 33.3%. Four spontaneous abortions occurred (11.8%), and 32 healthy children were born.

Conclusions:

This is the first prospective multicenter study on artificial oocyte activation in severe male factor infertility. Present data indicate that a ready-to-use calcium ionophore can yield high fertilization and pregnancy rates for this particular subgroup. In addition to fertilization failure after ICSI, severe male factor infertility is an additional area for application of artificial oocyte activation.

Read the full text at: http://www.fertstert.org/article/S0015-0282(12)01887-0/fulltext


Go to the profile of Fertility and Sterility

Fertility and Sterility

Editorial Office, American Society for Reproductive Medicine

Fertility and Sterility® is an international journal for obstetricians, gynecologists, reproductive endocrinologists, urologists, basic scientists and others who treat and investigate problems of infertility and human reproductive disorders. The journal publishes juried original scientific articles in clinical and laboratory research relevant to reproductive endocrinology, urology, andrology, physiology, immunology, genetics, contraception, and menopause. Fertility and Sterility® encourages and supports meaningful basic and clinical research, and facilitates and promotes excellence in professional education, in the field of reproductive medicine.

No comments yet.